Published in J Virol on December 01, 1994
Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol (2003) 2.60
A recombinant hepatitis C virus RNA-dependent RNA polymerase capable of copying the full-length viral RNA. J Virol (1999) 2.16
Characterization of the RNA components of a putative molecular switch in the 3' untranslated region of the murine coronavirus genome. J Virol (2004) 1.85
Cis-acting RNA elements in human and animal plus-strand RNA viruses. Biochim Biophys Acta (2009) 1.67
A phylogenetically conserved hairpin-type 3' untranslated region pseudoknot functions in coronavirus RNA replication. J Virol (1999) 1.56
A bulged stem-loop structure in the 3' untranslated region of the genome of the coronavirus mouse hepatitis virus is essential for replication. J Virol (1997) 1.48
Heterogeneous nuclear ribonucleoprotein a1 binds to the 3'-untranslated region and mediates potential 5'-3'-end cross talks of mouse hepatitis virus RNA. J Virol (2001) 1.41
Regulation of coronavirus mRNA transcription. J Virol (1995) 1.40
Host protein interactions with the 3' end of bovine coronavirus RNA and the requirement of the poly(A) tail for coronavirus defective genome replication. J Virol (2000) 1.40
Characterization of a murine coronavirus defective interfering RNA internal cis-acting replication signal. J Virol (1995) 1.36
Characterization of an essential RNA secondary structure in the 3' untranslated region of the murine coronavirus genome. J Virol (2000) 1.35
Replication and packaging of transmissible gastroenteritis coronavirus-derived synthetic minigenomes. J Virol (1999) 1.31
Specific interaction between the hepatitis C virus NS5B RNA polymerase and the 3' end of the viral RNA. J Virol (1999) 1.28
RNA-RNA and RNA-protein interactions in coronavirus replication and transcription. RNA Biol (2011) 1.21
Mitochondrial aconitase binds to the 3' untranslated region of the mouse hepatitis virus genome. J Virol (2001) 1.21
Stem-loop III in the 5' untranslated region is a cis-acting element in bovine coronavirus defective interfering RNA replication. J Virol (2003) 1.18
Evaluation of the role of heterogeneous nuclear ribonucleoprotein A1 as a host factor in murine coronavirus discontinuous transcription and genome replication. Proc Natl Acad Sci U S A (2001) 1.15
The 3' untranslated region of coronavirus RNA is required for subgenomic mRNA transcription from a defective interfering RNA. J Virol (1996) 1.14
cis-acting sequences required for coronavirus infectious bronchitis virus defective-RNA replication and packaging. J Virol (2001) 1.12
Polypyrimidine tract-binding protein binds to the complementary strand of the mouse hepatitis virus 3' untranslated region, thereby altering RNA conformation. J Virol (1999) 1.10
Genetic interactions between an essential 3' cis-acting RNA pseudoknot, replicase gene products, and the extreme 3' end of the mouse coronavirus genome. J Virol (2007) 1.09
RNA-RNA recombination in Sindbis virus: roles of the 3' conserved motif, poly(A) tail, and nonviral sequences of template RNAs in polymerase recognition and template switching. J Virol (1997) 1.07
Effect of mutations in the mouse hepatitis virus 3'(+)42 protein binding element on RNA replication. J Virol (2005) 1.07
RNA conformational changes in the life cycles of RNA viruses, viroids, and virus-associated RNAs. Biochim Biophys Acta (2009) 1.07
The 3' cis-acting genomic replication element of the severe acute respiratory syndrome coronavirus can function in the murine coronavirus genome. J Virol (2004) 1.06
Sequences at the 3' untranslated region of bamboo mosaic potexvirus RNA interact with the viral RNA-dependent RNA polymerase. J Virol (2001) 1.00
Secondary structural elements within the 3' untranslated region of mouse hepatitis virus strain JHM genomic RNA. J Virol (2001) 0.99
In vivo restoration of biologically active 3' ends of virus-associated RNAs by nonhomologous RNA recombination and replacement of a terminal motif. J Virol (1996) 0.98
Formation and amplification of a novel tombusvirus defective RNA which lacks the 5' nontranslated region of the viral genome. J Virol (1998) 0.97
A hypervariable region within the 3' cis-acting element of the murine coronavirus genome is nonessential for RNA synthesis but affects pathogenesis. J Virol (2006) 0.96
Coronavirus transcription early in infection. J Virol (1998) 0.95
Isolation and characterization of an arterivirus defective interfering RNA genome. J Virol (2000) 0.93
The leader RNA of coronavirus mouse hepatitis virus contains an enhancer-like element for subgenomic mRNA transcription. J Virol (2000) 0.89
Subgenomic messenger RNA amplification in coronaviruses. Proc Natl Acad Sci U S A (2010) 0.89
The structure and functions of coronavirus genomic 3' and 5' ends. Virus Res (2015) 0.87
Repair and polyadenylation of a naturally occurring hepatitis C virus 3' nontranslated region-shorter variant in selectable replicon cell lines. J Virol (2006) 0.86
An optimal cis-replication stem-loop IV in the 5' untranslated region of the mouse coronavirus genome extends 16 nucleotides into open reading frame 1. J Virol (2011) 0.85
Analysis of the 3' cis-acting elements of rubella virus by using replicons expressing a puromycin resistance gene. J Virol (2004) 0.82
A leaderless genome identified during persistent bovine coronavirus infection is associated with attenuation of gene expression. PLoS One (2013) 0.78
Identification of cis-acting elements on positive-strand subgenomic mRNA required for the synthesis of negative-strand counterpart in bovine coronavirus. Viruses (2014) 0.76
The 3'-terminal 55 nucleotides of bovine coronavirus defective interfering RNA harbor cis-acting elements required for both negative- and positive-strand RNA synthesis. PLoS One (2014) 0.76
Genome organization of the SARS-CoV. Genomics Proteomics Bioinformatics (2003) 0.75
RNA of mouse hepatitis virus. J Virol (1978) 4.27
Coronavirus transcription: subgenomic mouse hepatitis virus replicative intermediates function in RNA synthesis. J Virol (1990) 4.19
The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase. Virology (1991) 4.07
Coronavirus subgenomic minus-strand RNAs and the potential for mRNA replicons. Proc Natl Acad Sci U S A (1989) 3.65
Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch Gesamte Virusforsch (1974) 3.24
Coronavirus: organization, replication and expression of genome. Annu Rev Microbiol (1990) 3.20
Molecular cloning of the gene encoding the putative polymerase of mouse hepatitis coronavirus, strain A59. Virology (1989) 2.69
Mutational analysis of the sequence and structural requirements in brome mosaic virus RNA for minus strand promoter activity. J Mol Biol (1988) 2.41
A system for study of coronavirus mRNA synthesis: a regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion. J Virol (1991) 2.30
Minus-strand copies of replicating coronavirus mRNAs contain antileaders. J Virol (1991) 2.27
Coronavirus minus-strand RNA synthesis and effect of cycloheximide on coronavirus RNA synthesis. J Virol (1986) 2.26
A domain at the 3' end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs. J Virol (1991) 2.14
Optimization of targeted RNA recombination and mapping of a novel nucleocapsid gene mutation in the coronavirus mouse hepatitis virus. J Virol (1994) 2.09
Bovine coronavirus mRNA replication continues throughout persistent infection in cell culture. J Virol (1990) 1.92
Analysis of cis-acting sequences essential for coronavirus defective interfering RNA replication. Virology (1993) 1.89
Primary structure and translation of a defective interfering RNA of murine coronavirus. Virology (1988) 1.87
Subgenomic RNA synthesis directed by a synthetic defective interfering RNA of mouse hepatitis virus: a study of coronavirus transcription initiation. J Virol (1994) 1.85
Assembly of functional Sindbis virus RNA replication complexes: requirement for coexpression of P123 and P34. J Virol (1993) 1.83
Deletion mapping of a mouse hepatitis virus defective interfering RNA reveals the requirement of an internal and discontiguous sequence for replication. J Virol (1993) 1.71
Three different cellular proteins bind to complementary sites on the 5'-end-positive and 3'-end-negative strands of mouse hepatitis virus RNA. J Virol (1993) 1.64
Mechanism of coronavirus transcription: duration of primary transcription initiation activity and effects of subgenomic RNA transcription on RNA replication. J Virol (1992) 1.61
Coronavirus leader RNA regulates and initiates subgenomic mRNA transcription both in trans and in cis. J Virol (1994) 1.58
A hepatitis virus complicating studies with mouse leukemia. J Natl Cancer Inst (1961) 1.45
Requirement of the 5'-end genomic sequence as an upstream cis-acting element for coronavirus subgenomic mRNA transcription. J Virol (1994) 1.41
The 5' end of coronavirus minus-strand RNAs contains a short poly(U) tract. J Virol (1991) 1.23
MHV nucleocapsid synthesis in the presence of cycloheximide and accumulation of negative strand MHV RNA. Virus Res (1986) 0.94
A critical assessment of the RNAse protection assay as a means of determining exon sizes. Anal Biochem (1993) 0.89
Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail. Cell (1977) 7.23
Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science (1999) 6.21
Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA. Nature (1987) 4.52
Adenylic acid-rich sequence in RNAs of Rous sarcoma virus and Rauscher mouse leukaemia virus. Nature (1972) 4.49
RNA of mouse hepatitis virus. J Virol (1978) 4.27
The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase. Virology (1991) 4.07
Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3. J Virol (1981) 4.00
Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus. Proc Natl Acad Sci U S A (1984) 3.81
Human hepatitis delta virus RNA subfragments contain an autocleavage activity. Proc Natl Acad Sci U S A (1989) 3.51
Avian tumor virus RNA: a comparison of three sarcoma viruses and their transformation-defective derivatives by oligonucleotide fingerprinting and DNA-RNA hybridization. Proc Natl Acad Sci U S A (1973) 3.46
Ribonucleic acid components of murine sarcoma and leukemia viruses. Proc Natl Acad Sci U S A (1973) 3.42
Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J Virol (1988) 3.11
Presence of leader sequences in the mRNA of mouse hepatitis virus. J Virol (1983) 3.06
High-frequency RNA recombination of murine coronaviruses. J Virol (1986) 2.91
Replication of mouse hepatitis virus: negative-stranded RNA and replicative form RNA are of genome length. J Virol (1982) 2.86
Characterization of replicative intermediate RNA of mouse hepatitis virus: presence of leader RNA sequences on nascent chains. J Virol (1983) 2.80
Characterization of two RNA polymerase activities induced by mouse hepatitis virus. J Virol (1982) 2.46
The 3'-untranslated region of hepatitis C virus RNA enhances translation from an internal ribosomal entry site. J Virol (1998) 2.36
Further characterization of mRNA's of mouse hepatitis virus: presence of common 5'-end nucleotides. J Virol (1982) 2.34
Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein. Virology (1999) 2.33
Comparative analysis of RNA genomes of mouse hepatitis viruses. J Virol (1981) 2.30
Restriction enzyme sites on the avian RNA tumor virus genome. J Virol (1978) 2.29
Determination of the secondary structure of and cellular protein binding to the 3'-untranslated region of the hepatitis C virus RNA genome. J Virol (1997) 2.28
Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol (1998) 2.28
Occurrence of partial deletion and substitution of the src gene in the RNA genome of avian sarcoma virus. Proc Natl Acad Sci U S A (1977) 2.22
Recombination between nonsegmented RNA genomes of murine coronaviruses. J Virol (1985) 2.21
The 5'-end sequence of the murine coronavirus genome: implications for multiple fusion sites in leader-primed transcription. Virology (1987) 2.17
Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA. J Virol (1990) 2.17
A recombinant hepatitis C virus RNA-dependent RNA polymerase capable of copying the full-length viral RNA. J Virol (1999) 2.16
Leader sequences of murine coronavirus mRNAs can be freely reassorted: evidence for the role of free leader RNA in transcription. Proc Natl Acad Sci U S A (1986) 2.16
Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology (1983) 2.11
Phosphoproteins of murine hepatitis viruses. J Virol (1979) 2.07
Characterization of leader-related small RNAs in coronavirus-infected cells: further evidence for leader-primed mechanism of transcription. Virus Res (1985) 2.07
Study of Dengue virus infection in SCID mice engrafted with human K562 cells. J Virol (1998) 2.03
High-frequency leader sequence switching during coronavirus defective interfering RNA replication. J Virol (1989) 1.95
An internal polypyrimidine-tract-binding protein-binding site in the hepatitis C virus RNA attenuates translation, which is relieved by the 3'-untranslated sequence. Virology (1999) 1.90
Sequence and translation of the murine coronavirus 5'-end genomic RNA reveals the N-terminal structure of the putative RNA polymerase. J Virol (1987) 1.89
Analysis of efficiently packaged defective interfering RNAs of murine coronavirus: localization of a possible RNA-packaging signal. J Virol (1990) 1.88
Primary structure and translation of a defective interfering RNA of murine coronavirus. Virology (1988) 1.87
Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J Virol (1997) 1.84
Identification of a domain required for autoproteolytic cleavage of murine coronavirus gene A polyprotein. J Virol (1989) 1.82
Identification of a new transcriptional initiation site and the corresponding functional gene 2b in the murine coronavirus RNA genome. J Virol (1989) 1.77
Discontinuous transcription generates heterogeneity at the leader fusion sites of coronavirus mRNAs. J Virol (1988) 1.76
Generation and characterization of organ-tropism mutants of Japanese encephalitis virus in vivo and in vitro. Virology (1996) 1.76
Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. J Virol (1992) 1.75
Dacryocystorhinostomy with intraoperative mitomycin C. Ophthalmology (1997) 1.74
Identification of the catalytic sites of a papain-like cysteine proteinase of murine coronavirus. J Virol (1993) 1.74
Differential subcellular localization of hepatitis C virus core gene products. Virology (1995) 1.73
Defective-interfering particles of murine coronavirus: mechanism of synthesis of defective viral RNAs. Virology (1988) 1.73
Deletion mapping of a mouse hepatitis virus defective interfering RNA reveals the requirement of an internal and discontiguous sequence for replication. J Virol (1993) 1.71
Heterogeneous nuclear ribonucleoprotein A1 binds to the transcription-regulatory region of mouse hepatitis virus RNA. Proc Natl Acad Sci U S A (1997) 1.70
Persistence of Japanese encephalitis virus is associated with abnormal expression of the nonstructural protein NS1 in host cells. Virology (1996) 1.69
An in vitro system for the leader-primed transcription of coronavirus mRNAs. EMBO J (1990) 1.69
Genome of avian myelocytomatosis virus MC29: analysis by heteroduplex mapping. Proc Natl Acad Sci U S A (1979) 1.68
Phosphoproteins of Rous sarcoma viruses. Virology (1976) 1.67
Colocalization and membrane association of murine hepatitis virus gene 1 products and De novo-synthesized viral RNA in infected cells. J Virol (1999) 1.67
Differences between the envelope glycoproteins and glycopeptides of avian tumor viruses released from transformed and from nontransformed cells. Virology (1972) 1.67
Further characterization of mouse hepatitis virus RNA-dependent RNA polymerases. Virology (1984) 1.64
Three different cellular proteins bind to complementary sites on the 5'-end-positive and 3'-end-negative strands of mouse hepatitis virus RNA. J Virol (1993) 1.64
Characterization of nuclear targeting signal of hepatitis delta antigen: nuclear transport as a protein complex. J Virol (1992) 1.63
Murine coronaviruses: isolation and characterization of two plaque morphology variants of the JHM neurotropic strain. J Gen Virol (1982) 1.62
Heterogeneity of gene expression of the hemagglutinin-esterase (HE) protein of murine coronaviruses. Virology (1991) 1.60
Reversible cleavage and ligation of hepatitis delta virus RNA. Science (1989) 1.59
Coronavirus leader RNA regulates and initiates subgenomic mRNA transcription both in trans and in cis. J Virol (1994) 1.58
Random nature of coronavirus RNA recombination in the absence of selection pressure. Virology (1991) 1.57
RNA-binding activity of hepatitis delta antigen involves two arginine-rich motifs and is required for hepatitis delta virus RNA replication. J Virol (1993) 1.57
Sequence conservation and divergence of hepatitis delta virus RNA. Virology (1990) 1.56
Analysis of intracellular small RNAs of mouse hepatitis virus: evidence for discontinuous transcription. Virology (1987) 1.52
Transcription of hepatitis delta antigen mRNA continues throughout hepatitis delta virus (HDV) replication: a new model of HDV RNA transcription and replication. J Virol (1998) 1.51
Homotypic interaction and multimerization of hepatitis C virus core protein. Virology (1996) 1.51
DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J Virol (1998) 1.49
Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese. Clin Pharmacol Ther (1989) 1.48
Template requirement and initiation site selection by hepatitis C virus polymerase on a minimal viral RNA template. J Biol Chem (2000) 1.46
Sequence and structure of the catalytic RNA of hepatitis delta virus genomic RNA. J Mol Biol (1992) 1.44
17-year follow-up of a randomized prospective controlled trial of adjuvant intravesical doxorubicin in the treatment of superficial bladder cancer. Int Braz J Urol (2005) 1.44
Evolution of the 5'-end of genomic RNA of murine coronaviruses during passages in vitro. Virology (1989) 1.43
Interaction of RAFT1 with gephyrin required for rapamycin-sensitive signaling. Science (1999) 1.42
Immunophilins in the nervous system. Neuron (1998) 1.42
Requirement of the 5'-end genomic sequence as an upstream cis-acting element for coronavirus subgenomic mRNA transcription. J Virol (1994) 1.41
Heterogeneous nuclear ribonucleoprotein a1 binds to the 3'-untranslated region and mediates potential 5'-3'-end cross talks of mouse hepatitis virus RNA. J Virol (2001) 1.41
Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J Virol (1997) 1.40
Heterogeneous nuclear ribonucleoprotein A1 regulates RNA synthesis of a cytoplasmic virus. EMBO J (2000) 1.38
Neurabin is a synaptic protein linking p70 S6 kinase and the neuronal cytoskeleton. Proc Natl Acad Sci U S A (1998) 1.38
Neuropathogenicity of mouse hepatitis virus JHM isolates differing in hemagglutinin-esterase protein expression. J Neurovirol (1995) 1.37
Automated HPLC screening of newborns for sickle cell anemia and other hemoglobinopathies. Clin Chem (1996) 1.37
RNA-Dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases. Mol Cell Biol (2000) 1.36
A pregnancy-specific glycoprotein is expressed in the brain and serves as a receptor for mouse hepatitis virus. Proc Natl Acad Sci U S A (1995) 1.34
Replication of hepatitis delta virus RNA: effect of mutations of the autocatalytic cleavage sites. J Virol (1993) 1.34
Hepatitis C virus NS5B protein is a membrane-associated phosphoprotein with a predominantly perinuclear localization. Virology (1997) 1.33
In vivo RNA-RNA recombination of coronavirus in mouse brain. J Virol (1988) 1.33
Multiple recombination sites at the 5'-end of murine coronavirus RNA. Virology (1987) 1.32
Chromosome 1 contains the endogenous RAV-0 retrovirus sequences in chicken cells. Proc Natl Acad Sci U S A (1979) 1.32
Oligomerization of hepatitis delta antigen is required for both the trans-activating and trans-dominant inhibitory activities of the delta antigen. J Virol (1992) 1.32
Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K. J Biol Chem (1998) 1.32
Regulation at the phosphoenolpyruvate branchpoint in Azotobacter vinelandii: pyruvate kinase. J Bacteriol (1971) 1.31
RNA conformational requirements of self-cleavage of hepatitis delta virus RNA. Mol Cell Biol (1990) 1.30
In vitro synthesis and characterisation of full- and half-genome length complementary DNA from avian oncoviruses. Nature (1978) 1.29
Avian erythroblastosis virus: transformation-specific sequences form a contiguous segment of 3.25 kb located in the middle of the 6-kb genome. Virology (1979) 1.29